Full Text View
Tabular View
No Study Results Posted
Related Studies
4-Methylumbelliferone as a Treatment for Chronic HBV/HCV
The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2006 by MTmedical Institute of Health.
Recruitment status was  Active, not recruiting
Study NCT00225537   Information provided by MTmedical Institute of Health

First Received on June 30, 2005.   Last Updated on September 7, 2006   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Chronic Hepatitis C
Chronic Hepatitis B
Additional conditions recognized in this trial
Hepatitis
Hepatitis A
Hepatitis B
Hepatitis B, Chronic
Hepatitis C
Hepatitis C, Chronic
Hepatitis, Chronic
More general conditions related to this trial
Digestive System Diseases
DNA Virus Infections
Enterovirus Infections
Flaviviridae Infections
Hepadnaviridae Infections
Hepatitis, Viral, Human
Liver Diseases
Picornaviridae Infections
RNA Virus Infections
Virus Diseases
Interventions listed in this trial
4-Methylumbelliferone (Heparvit®)
Sponsors listed in this trial
MTmedical Institute of Health
The University of Texas Health Science Center at San Antonio
BioMonde Preparations Limited


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services